These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35452635)

  • 1. Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE
    Life Sci; 2022 Jul; 300():120560. PubMed ID: 35452635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of adipose-hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-κB/NLRP3 repression.
    Olaniyi K; Areloegbe S
    Can J Physiol Pharmacol; 2023 Dec; 101(12):630-641. PubMed ID: 37590975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE
    J Steroid Biochem Mol Biol; 2023 Jan; 225():106179. PubMed ID: 36150640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model.
    Olaniyi KS; Bashir AM; Areloegbe SE; Sabinari IW; Akintayo CO; Oniyide AA; Aturamu A
    PLoS One; 2022; 17(7):e0272124. PubMed ID: 35881588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3.
    Olaniyi KS; Areloegbe SE
    Nutrition; 2023 Mar; 107():111914. PubMed ID: 36521396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation.
    Wolugbom JA; Areloegbe SE; Olaniyi KS
    Mol Neurobiol; 2023 Jan; 60(1):355-368. PubMed ID: 36269541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS.
    Olaniyi KS; Oniyide AA; Adeyanju OA; Ojulari LS; Omoaghe AO; Olaiya OE
    Toxicol Appl Pharmacol; 2021 Jan; 411():115381. PubMed ID: 33359182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE; Areola ED; Sabinari IW; Fafure AA; Agbana RD; Atuma CL; Shah MZUH; Ajadi IO; Olatunji LA
    Toxicol Appl Pharmacol; 2023 Aug; 473():116604. PubMed ID: 37328115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2.
    Olaniyi KS; Areloegbe SE
    J Physiol Sci; 2024 Apr; 74(1):22. PubMed ID: 38561673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac energy depletion in a rat model of polycystic ovarian syndrome is reversed by acetate and associated with inhibitory effect of HDAC2/mTOR.
    Olaniyi KS; Areloegbe SE; Fiemotongha FE
    Eur J Pharmacol; 2024 Jan; 962():176243. PubMed ID: 38048978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.
    Olaniyi KS; Areloegbe SE; Oyeleke MB
    Endocrine; 2022 Dec; 78(3):628-640. PubMed ID: 36114434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetate attenuates hypothalamic pyroptosis in experimentally induced polycystic ovarian syndrome.
    Olaniyi KS; Agan SU; Areloegbe SE; Sabinari IW; Oniyide AA; Enye LA; Omoaghe AO; Adekeye AO; Adeoluwa OA
    BMC Res Notes; 2024 Sep; 17(1):260. PubMed ID: 39267194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model.
    Areloegbe SE; Peter MU; Oyeleke MB; Olaniyi KS
    BMC Endocr Disord; 2022 Sep; 22(1):224. PubMed ID: 36071485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model.
    Peter MU; Areloegbe SE; Akintayo CO; Oniyide AA; Aturamu A; Olaniyi KS
    Can J Physiol Pharmacol; 2022 Sep; 100(9):890-902. PubMed ID: 35771488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1.
    Bashir AM; Olaniyi KS
    BMC Pharmacol Toxicol; 2023 Oct; 24(1):48. PubMed ID: 37789355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS.
    Eepho OI; Bashir AM; Oniyide AA; Aturamu A; Owolabi OV; Ajadi IO; Fafure AA; Ajadi MB; Areloegbe SE; Olaniyi KS
    BMC Neurosci; 2023 Nov; 24(1):62. PubMed ID: 37996797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1.
    Areloegbe SE; Olaniyi KS
    Biochem Biophys Res Commun; 2023 Nov; 681():62-72. PubMed ID: 37757668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome.
    Bukke SPN; Pathange BBR; Karumanchi SK; Marri J; Boyina R; Rachamsetty K; Manchikalapati B; Odoma S; Hussaini B
    J Ovarian Res; 2023 Nov; 16(1):221. PubMed ID: 37993900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
    Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
    J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partially purified non-polar phytocomponents from Aloe barbadensis Mill. gel restores metabolic and reproductive comorbidities in letrozole-induced polycystic ovary syndrome rodent model- an "in-vivo" study.
    Dey A; Dhadhal S; Maharjan R; Nagar PS; Nampoothiri L
    J Ethnopharmacol; 2022 Jun; 291():115161. PubMed ID: 35271948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.